Physician

Ahmad Muhammad Salah, D.O

According to 2025 Medicare claims, Ahmad Salah, D.O (NPI: 1285909481) practices rheumatology in the Lake County-Porter County-Jasper County, IN market, with the plurality of this provider's patient population coming from Lake, IN. This provider's primary affiliated billing organization is RHEUMATOLOGY TREATMENT CENTERS OF AMERICA (NPI: 1568284339) and primary practice location at 46410-7160. Salah is affiliated with the Franciscan ACO, Inc. (ACO ID: A2550) and IRCCO (ACO ID: A2619), participating under the MSSP model.

Salah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 288 traditional Medicare patients, billed 1,092 HCPCS/CPT codes, and received $48,229 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 3,173 prescription claims across 436 beneficiaries totaling $4,781,033 in drug costs, led by Rinvoq (Upadacitinib). 2020 DME data shows 22 claims. Open Payments data shows 110 records totaling $41,122. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $13,187 and ending at $48,229. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $39,905 to $4,781,033. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	107	205	$13,187
2018	395	855	$67,761
2019	460	1,249	$79,853
2020	364	772	$54,059
2021	402	815	$81,077
2022	363	707	$73,360
2023	382	745	$76,467
2024	288	1,092	$48,229

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	94	282	$39,905
2016	121	537	$198,494
2017	161	606	$453,474
2018	339	1,394	$608,370
2019	376	2,362	$1,818,788
2020	384	2,500	$2,720,652
2021	408	2,987	$3,368,814
2022	392	2,882	$3,661,022
2023	400	3,035	$4,231,669
2024	436	3,173	$4,781,033

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	22	$1,034
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	32	32	$125
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	197	306	$106
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	14	14	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	55	62	$78
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	187	262	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rinvoq	Upadacitinib	193	5,898	$1,336,033
Humira(Cf) Pen	Adalimumab	122	3,592	$1,163,298
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	30	840	$228,509
Enbrel Sureclick	Etanercept	29	868	$224,717
Orencia Clickject	Abatacept	31	868	$182,974

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	110	$41,122	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmad Muhammad Salah, D.O?

Tedicare shows public-source Medicare data for Ahmad Muhammad Salah, D.O (NPI 1285909481), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmad Muhammad Salah, D.O have ACO affiliation data?

Ahmad Muhammad Salah, D.O is shown with ACO affiliation data for Franciscan ACO, Inc. (MSSP, ACO ID A2550) and IRCCO (MSSP, ACO ID A2619).

What billing organization is linked to Ahmad Muhammad Salah, D.O?

Ahmad Muhammad Salah, D.O is linked to RHEUMATOLOGY TREATMENT CENTERS OF AMERICA (billing NPI 1568284339) in the available physician profile data.

Does Ahmad Muhammad Salah, D.O have Open Payments data?

Ahmad Muhammad Salah, D.O has 110 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.